Endothelial dysfunction in hypertension: cause or effect?
https://doi.org/10.15829/1728-8800-2019-6-62-68
Abstract
Hypertension remains a pandemic of the 21st century, being a major factor of premature death. The introduction of imaging methods into clinical practice revealed a high prevalence of target organ damage mediated by hypertension. One of the systemic target organs in hypertension is endothelium. Its damage plays an important role in the initiation of the cardiovascular disease continuum. On the other hand, structure and function defects of the endothelium is considered as a possible reason for the increase in blood pressure. This literature review systematizes data on a causal relationship between hypertension and endothelial dysfunction, and discusses the direction of further study of vascular endothelium function.
About the Authors
A. Yu. Gorshkov
National Medical Research Center for Preventive Medicine
Russian Federation
Russian Federation
Moscow.
A. A. Fedorovich
National Medical Research Center for Preventive Medicine
Russian Federation
Russian Federation
Moscow.
O. M. Drapkina
National Medical Research Center for Preventive Medicine
Russian Federation
Russian Federation
Moscow.
References
1. Florey L. The endothelial cell. Br Med J. 1966;2(5512):487-90. doi: 10.1136/bmj.2.5512.487.
2. Furchgott RF, Zawadzki JV. The obligatory role of the endothelial cells in relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373-6.
3. Lupinskaya ZA, Zarif'yan AG, Gurovich TTs, et al. Endothelium. Function and dysfunction. Bishkek: Kyrgyz State Medical Academy, 2008. p. 373. (In Russ.)
4. Vita J. A., Keaney J. F. Endothelial function. Circulation. 2011;124(25):e906-12. doi:10.1161/CIRCULATIONAHA.111.078824.
5. Konukoglu D, Uzun H. Endothelial dysfunction and hypertension. Adv Exp Med Biol. 2017;956:511-40. doi:10.1007/5584201690.
6. Rajendran P, Rengarajan T, Thangavel J, et al. The Vascular Endothelium and Human Diseases . Int J Biol Sci. 2013; 9(10):1057-69. doi:10.7150/ijbs.7502.
7. Vasina LV, Petrishchev NN, Vlasov TD. Markers of endothelial dysfunction. Regionarnoe krovoobrashhenie i mikrocirkulyaciya. 2017; 16( 1):4-15. (In Russ.)
8. Panza JA, Quyyumi AA, Brush JE Jr, et al. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323(1):22-7. doi:10.1056/NEJM199007053230105.
9. Bauer UE, Briss PA, Goodman RA, et al. Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA. Lancet. 2014;384:45-52. doi:10.1016/S0140-6736(14)60648-6.
10. Lekakis J, Abraham P, Balbarini A, et al. Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation. Eur J Cardiovasc Prev Rehabil. 2011;18(6):775-89. doi:10.1177/1741826711398179.
11. Li LJ, Geng SR, Yu CM. Endothelial dysfunction in normotensive Chinese with a family history of essential hypertension. Clinical and Experimental Hypertension. 2005;27(1):1-8. doi:10.1081/CEH-200044242.
12. Zanina EV, Chistyakova GN, Gazieva LA. Endothelial function in term infants born to women with hypertension. Pediatriya. 2013;92(2):21-3. (In Russ.)
13. Taddei S, Virdis A, Mattei P, et al. Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation. 1996;94(6):1298-303. doi:10.1161/01.cir.94.6.1298.
14. Bond VJr, Becknel K, Kumar K, et al. Association of Endothelial Function with Parental Hypertension in Normotensive-Obese African-American Women: A Pilot Study. Adv Prev Med. 2019;2019:5854219. doi:10.1155/2019/5854219.
15. Schlaich MP, Parnell MM, Ahlers BA, et al. Impaired L-arginine transport and endothelial function in hypertensive and genetically predisposed normotensive subjects. Circulation. 2004;110:3680-6. doi:10.1161/01.CIR.0000149748.79945.52.
16. Flammer AJ, Luscher TF. Human endothelial dysfunction: EDRFs. Pflugers Arch. 2010;459(6):1005-13. doi:10.1007/s00424-010-0822-4.
17. Hirst A, Marshall JM. Endothelium-dependent and cyclooxygenase-dependent cutaneous vasodilatation is blunted in young men with hypertensive parents. J Hypertens. 2018;36(11):2140-7. doi:10.1097/HJH.0000000000001794.
18. Zizek B, Poredos P, Videcnik V. Endothelial dysfunction in hypertensive patients and in normotensive offspring of subjects with essential hypertension. Heart. 2001;85(2):215-7. doi:10.1136/heart.85.2.215.
19. Dow CA, Stauffer BL, Greiner JJ, et al. Influence of habitual high dietary fat intake on endothelium-dependent vasodilation. Appl Physiol Nutr. Metab. 2015;40(7):711-5. doi:10.1139/apnm-2015-0006.
20. Edwards DG, Farquhar WB. Vascular effects of dietary salt. Current Opinion in Nephrology and Hypertension. 2015;24(1):8-13. doi:10.1097/MNH.0000000000000089.
21. Ozkor MA, Rahman AM, Murrow JR, et al. Differences in vascular nitric oxide and endothelium-derived hyperpolarizing factor bioavailability in blacks and whites. Arterioscler Thromb Vasc Biol. 2014;34:1320-7. doi:10.1161/ATVBAHA.113.303136.
22. Zhang Y, Thompson AM, Tong W, et al. Biomarkers of inflam- mation and endothelial dysfunction and risk of hypertension among Inner Mongolians in China. J Hypertens. 2010;28(1):35-40. doi:10.1097/HJH.0b013e3283324650.
23. Vatutin NT, Sklyannaya EV. Endothelial dysfunction as a risk factor of arterial hypertension progression. The Siberian Medical J. 2017;32(4):23-7. (In Russ.)
24. Murakami T, Arai Y. Endothelial dysfunction accelerates hypertensive evolution. JACC. 2002;39(Supplement 1) 222. doi:10.1016/S0735-1097(02)80989-5.
25. Caballero-Eraso C, Munoz-Hernandez R, Asensio Cruz MI, et al. Relationship between the endothelial dysfunction and the expression of the 01-subunit of BK channels in a non-hypertensive sleep apnea group. PLoS One. 2019;14(6):e0217138. doi:10.1371/journal.pone.0217138.
26. Jin ZN, Wei YX. Meta-analysis of effects of obstructive sleep apnea on the renin-angiotensin-aldosterone system. J Geriatr Cardiol. 2016; 13(4):333-43 doi:10.11909/j.issn.1671-5411.2016.03.020.
27. Schwarz EI, Puhan MA, Schlatzer C, et al. Effect of CPAP therapy on endothelial function in obstructive sleep apnoea: A systematic review and meta-analysis. Respirology. 2015;20(6):889-95. doi:10.1111/resp.12573.
28. Ribeiro MO, Antunes E, de Nucci G, et al. Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension. 1992;20(3):298-303. doi:10.1161/01.hyp.20.3.298.
29. Napoli C, Ignarro LJ. Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases. Arch Pharm Res. 2009;32(8):1103-8. doi:10.1007/s12272-009-1801-1.
30. Bernatova I, Pechanova O, Babal P, et al. Wine polyphenols improve cardiovascular remodeling and vascular function in NO-deficient hypertension. Am J Physiol Heart Circ Physiol. 2002;282(3):H942-8. doi:10.1152/ajpheart.00724.2001.
31. Dillenburg DR, Mostarda C, Moraes-Silva IC, et al. Resveratrol and grape juice differentially ameliorate cardiovascular autonomic modulation in L-NAME-treated rats. Auton Neurosci. 2013;179(1-2):9-13. doi:101016/j.autneu.2013.06.002.
32. Nakmareong S, Kukongviriyapan U, Pakdeechote P, et al. Tetrahydrocurcumin alleviates hypertension, aortic stiffening and oxidative stress in rats with nitric oxide deficiency. Hypertens Res. 2012;35(4):418-25. doi:10.1038/hr.2011.180.
33. Angus JA, Lew MJ. Interpretation of the acetylcholine test of endothelial cell dysfunction in hypertension. J. Hypertension. 1992;10(7):S179-86.
34. Valente FM, Vespasiano P, et al. Endothelial Changes in Individuals with Prehypertension. Curr Hypertens Rev. 2016;12(2):134-8.
35. Weil BR, Westby CM, Greiner JJ, et al. Elevated endothelin-1 vasoconstrictor tone in prehypertensive adults. Can J Cardiol. 2012;28(3):347-53. doi:10.1016/j.cjca.2011.11.006.
36. Versari D, Daghini E, Virdis A, et al. Endothelium-dependent contractions and endothelial dysfunction in human hypertension. Br J Pharmacol. 2009;157(4):527-36. doi:10.1111/j.1476-5381.2009.00240.x.
37. Lamping KG, Dole WP. Acute hypertension selectively potentiates constrictor responses of large coronary arteries to serotonin by altering endothelial function in vivo. Circ Res. 1987;61(6):904-13. doi:10.1161/01.res.61.6.904.
38. Miller MJS, Pinto A, Mullane KM. Impaired endothelium-dependent relaxations in rabbits subjected to aortic coarctation hypertension. Hypertension. 1987;10(2):164-70. doi:10.1161/01.hyp.10.2.164.
39. Luscher TF, Vanhoutte PM, Raij L. Antihypertensive treatment normalizes decreased endothelium-dependent relaxations in rats with salt-induced hypertension. Hypertension. 1987;9(6 Pt 2):III193-7. doi:10.1161/01.hyp.9.6_pt_2.iii193.
40. Hongo K, Nakagomi T, Kassell NF, et al. Effects of aging and hypertension on endothelium-dependent vascular relaxation in rat carotid artery. Stroke. 1988;19(7):892-7. doi:10.1161/01.str.19.7.892.
41. Takase H, Moreau P, Kung CF, et al. Antihypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency. Effect of verapamil and trandolapril. Hypertension.1996;27(1):25-31. doi:10.1161/01.hyp.27.1.25.
42. Luscher TF, Dohi Y, Tschudi M. Endothelium-dependent regulation of resistance arteries: alterations with aging and hypertension. J Cardiovasc Pharmacol. 1992;19 Suppl 5:S34-42.
43. Angus JA, Jennings GL, Sudhir K. Enhanced contraction to noradrenaline, serotonin and nerve stimulation but normal endothelium-derived relaxing factor response in skin small arteries in human primary hypertension. Clin Exp Pharmacol Physiol Suppl. 1992;19:39-47.
44. Deng LY, Li JS, Schiffrin EL. Endothelium-dependent relaxation of small arteries from essential hypertensive patients: mechanisms and comparison with normotensive subjects and with responses of vessels from spontaneously hypertensive rats. Clin Sci (Lond). 1995;88(6):611-22.
45. Rizzoni D, Porteri E, Castellano M, et al. Endothelial dysfunction in hypertension is independent from the etiology and from vascular structure. Hypertension. 1998;31(1 Pt 2):335-41. doi: 10.1161/01.hyp.31.1.335.
46. Andrianov EN, Ryvkin AI, Busova OA, et al. The relationship of the hemodynamic profile and the functional state of the vascular endothelium in adolescents with high normal blood pressure. Pediatriya. 2008;87(2):15-8. (In Russ).
47. Juonala M, Viikari JS, Ronnemaa T, et al. Elevated blood pressure in adolescent boys predicts endothelial dysfunction: the cardiovascular risk in young Finns study. Hypertension. 2006;48(3):424-30. doi:10.1161/01.HYP.0000237666.78217.47.
48. Shimbo D, Muntner P, Mann D. et al. Endothelial dysfunction and the risk of hypertension: the multi-ethnic study of atherosclerosis. Hypertension. 2010;55(5):1210-6. doi:10.1161/HYPERTENSIONAHA.109.143123.
49. Lytsy P, Lind L, Sundstrom J. Endothelial function and risk of hypertension and blood pressure progression: The prospective investigation of the vasculature in Uppsala seniors. Journal of Hypertension. 2013;31(5):936-9. doi: 10.1097/HJH.0b013e32835ed5a0.
50. Higashi Y, Sasaki S, Kurisu S, et al. Regular aerobic exercise augments endothelium- dependent vascular relaxation in normotensive as well as hypertensive subjects: role of endothelium-derived nitric oxide. Circulation. 1999; 100(11): 1194-202. doi:10.1161/01.cir.100.11.1194.
51. Schiffrin EL, Deng LY. Comparison of effects of angiotensin I-converting enzyme inhibition and в-blockade for 2 years on function of small arteries from hypertensive patients. Hypertension. 1995;25(4 Pt 2):699-703. doi:10.1161/01.hyp.25.4.699.
52. Tang EH, Vanhoutte PM. Endothelial dysfunction: a strategic target in the treatment of hypertension? Pflugers Arch. 2010;459(6):995-1004. doi: 10.1007/s00424-010-0786-4.
53. Bleakley C, Hamilton PK, Pumb R, et al. Endothelial Function in Hypertension: Victim or Culprit? J Clin Hypertens (Greenwich). 2015;17(8):651-4. doi:10.1111/jch.12546.
54. Lilly B. We have contact: endothelial cell-smooth muscle cell interactions. Physiology. 2014;29(4):234-41. doi:10.1152/physiol.00047.2013.
55. Badri KR, Yue M, Carretero OA, et al. Blood pressure homeostasis is maintained by a P311-TGF-beta axis. J Clin Invest. 2013;123(10):4502-12. doi:10.1172/JCI69884.
56. Kimura C, Konishi S, Hasegawa M, et al. Development of vascular smooth muscle contractility by endothelium-derived transforming growth factor beta proteins. Pflugers Arch. 2014;466(2):369-80. doi:10.1007/s00424-013-1329-6.
57. Virdis A, Taddei S. Endothelial dysfunction in resistance arteries of hypertensive humans. Journal of Cardiovascular Pharmacology. 2016;67(6):451-7. doi:10.1097/FJC.0000000000000362.
58. Vasina LV, Vlasov TD, Petrishchev NN. Functional heterogeneity of the endothelium (the review). Arterial Hypertension. 2017;23(2):88-102. doi:10.18705/1607-419X-2017-23-2-88-102.
59. Dai G, Kaazempur-Mofrad MR, Natarajan S, et al. Distinct endothelial phenotypes evoked by arterial waveforms derived from atherosclerosissusceptible and resistant regions of human vasculature. Proc Natl Acad Sci USA. 2004;101(41):14871-6. doi:10.1073/pnas.0406073101.
60. Redmond EM, Cahill PA, Sitzmann JV. Flow-mediated regulation of G-protein expression in cocultured vascular smooth muscle and endothelial cells. Arterioscler Thromb Vasc Biol. 1998;18(1):75-83.
61. Kuchan MJ, Frangos JA. Shear stress regulates endothelin-1 release via protein kinase C and cGMP in cultured endothelial cells. Am J Physiol. 1993;264(1 Pt 2):H150-6. doi:10.1152/ajpheart.1993.264.1.H150.
62. Jacob M, Rehm M, Loetsch M, et al. The endothelial glycocalyx prefers albumin for evoking shear stress-induced, nitric oxide-mediated coronary dilatation J Vasc Res. 2007;44(6):435-43. doi:10.1159/000104871.
63. Zweier JL, Talukder MA. The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res. 2006;70(2):181-90. doi:10.1016/j.cardiores.2006.02.025.
64. Levy BI, Ambrosio G, Pries AR, et al. Microcirculation in Hypertension: A New Target for Treatment? Circulation. 2001;104(6):735-40. doi:10.1161/hc3101.091158.
65. Cardona A, Kondapally Seshasai SR, Davey J, et al. A meta-analysis of published studies of endothelial dysfunction does not support its routine clinical use. Int J Clin Pract. 2015;69(6):649-58. doi:10.1111/ijcp.12630.
Review
For citations:
Gorshkov A.Yu., Fedorovich A.A., Drapkina O.M. Endothelial dysfunction in hypertension: cause or effect? Cardiovascular Therapy and Prevention. 2019;18(6):62-68. (In Russ.) https://doi.org/10.15829/1728-8800-2019-6-62-68
Views:
2310
Email this article 
